SCHEMBL7714628

SCHEMBL7714628

Cc1cc(O)cc(CC#N)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.48
MMP3 P08254 1/20 0.41
KDM4E B2RXH2 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
HCAR1 Q9BXC0 1/20 0.36
ENPP2 Q13822 1/20 0.35
ACHE P22303 3/20 0.34
THRB P10828 1/20 0.33
PTGS2 P35354 3/20 0.32
PGK1 P00558 1/20 0.32
PGK2 P07205 1/20 0.32
CYP3A4 P08684 1/20 0.32
POLB P06746 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31
SELL P14151 1/20 0.31
SELP P16109 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1823353 0.84 KDM4E (0.43) ALDH1A1MMP3KDM4ETDP1ENPP2
SCHEMBL2262582 0.84 KDM4E (0.43) MMP3KDM4ETDP1ENPP2THRB
SCHEMBL1050898 0.84 ACHE (0.48) MMP3KDM4ETDP1ENPP2ACHE
SCHEMBL12883530 0.77 KDM4E (0.38) MMP3KDM4ETDP1ENPP2THRB
SCHEMBL25170271 0.75 CA12 (0.48) MMP3KDM4ETDP1HCAR1ENPP2
SCHEMBL10222056 0.75 KDM4E (0.37) MMP3KDM4ETDP1ENPP2THRB
SCHEMBL306934 0.75 TACR1 (0.37) ALDH1A1MMP3KDM4ETDP1ENPP2
SCHEMBL21507689 0.75 ALDH1A1 (0.50) ALDH1A1MMP3KDM4ETDP1ENPP2
SCHEMBL20576683 0.75 KDM4E (0.37) MMP3KDM4ETDP1ENPP2ACHE
SCHEMBL641274 0.75 KDM4E (0.37) MMP3KDM4ETDP1ENPP2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376512-B1 FOR TREATING PHYSIOLOGICAL CONDITION IN PATIENT WHEREIN SAID CONDITION IS ASSOCIATED WITH A PHYSIOLOGICALLY DETRIMENTAL LEVELS OF INSULIN, GLUCOSE, FREE FATTY ACIDS, OR TRIGLYCERIDES AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-04-23 US disclosed
US-5059610-A QUINOLINE DERIVATIVES AND THEIR USE AS ANTAGONISTS OF LEUKOTRIENE D4 RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1991-10-22 US disclosed
US-4920132-A Quinoline derivatives and use thereof as antagonists of leukotriene D4 RORER PHARMACEUTICAL CORP. (US) 1990-04-24 US disclosed